FTC Settles Deceptive Diabetes Claim with “Nobetes” Marketers

A company that marketed and sold a pill called Nobetes, has settled with the Federal Trade Commission (“FTC”) in a case that alleged that the company falsely advertised the Nobetes pill they claimed treated diabetes. The FTC Complaint alleges that from 2015 through 2018, the Nobetes Corporation along with the officers, Marvin Silver and Jeffrey Fleitman, advertised the Nobetes pill on television, radio, Facebook and YouTube. In those advertisements, claims of “all-natural supplement, large reductions in blood sugar levels, reduction of use of insulin, helps control blood sugar within normal levels, 35 supplements that can fill the nutritional shortages that diabetes causes, this is a miracle product you’ve been waiting for, treats diabetes, keeps blood sugar within normal levels and reduces of eliminates the need for medications such as insulin”, are false or unsubstantiated. The complaint alleges that in the promotional materials and advertising that Mitch Darnell was a scientific or medical expert but in fact he was an actor to promote Nobetes. There was no disclosure that the consumer endorsers were supplied with free products. The complaint also alleges that the defendants misused the credit card information for consumers by using the consumer credit card offer again after the shipping and handling charges for the free bottle 30 days later for another shipment of the product.